Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder Cancer
Am J Case Rep. 2025 Sep 28;26:e948323. doi: 10.12659/AJCR.948323. ABSTRACT BACKGROUND Immune checkpoint inhibitors (ICI) like pembrolizumab are increasingly used […]
